showed a trendp = 0.356
Subgroup analyses Patients after OHCA (Additional file 1 : Table S4) showed a trend towards higher 30-day mortality rate when treated with balanced crystalloids group that did not reach statistical significance (53.2% vs 46.7%, p = 0.356, Fig. 4 A).